Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1108521.RA4lmi8dZb-rRia8bv6fDGRsYhZLM-fdBnYoioPwbh5E8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1108521.RA4lmi8dZb-rRia8bv6fDGRsYhZLM-fdBnYoioPwbh5E8130_assertion type Assertion NP1108521.RA4lmi8dZb-rRia8bv6fDGRsYhZLM-fdBnYoioPwbh5E8130_head.
- NP1108521.RA4lmi8dZb-rRia8bv6fDGRsYhZLM-fdBnYoioPwbh5E8130_assertion description "[Our findings suggest that lymphotoxin-LTBR and CXCL11-CXCR3 signalling represent therapeutic targets in ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1108521.RA4lmi8dZb-rRia8bv6fDGRsYhZLM-fdBnYoioPwbh5E8130_provenance.
- NP1108521.RA4lmi8dZb-rRia8bv6fDGRsYhZLM-fdBnYoioPwbh5E8130_assertion evidence source_evidence_literature NP1108521.RA4lmi8dZb-rRia8bv6fDGRsYhZLM-fdBnYoioPwbh5E8130_provenance.
- NP1108521.RA4lmi8dZb-rRia8bv6fDGRsYhZLM-fdBnYoioPwbh5E8130_assertion SIO_000772 24014111 NP1108521.RA4lmi8dZb-rRia8bv6fDGRsYhZLM-fdBnYoioPwbh5E8130_provenance.
- NP1108521.RA4lmi8dZb-rRia8bv6fDGRsYhZLM-fdBnYoioPwbh5E8130_assertion wasDerivedFrom befree-2016 NP1108521.RA4lmi8dZb-rRia8bv6fDGRsYhZLM-fdBnYoioPwbh5E8130_provenance.
- NP1108521.RA4lmi8dZb-rRia8bv6fDGRsYhZLM-fdBnYoioPwbh5E8130_assertion wasGeneratedBy ECO_0000203 NP1108521.RA4lmi8dZb-rRia8bv6fDGRsYhZLM-fdBnYoioPwbh5E8130_provenance.